Treatment of hepatocellular carcinoma

被引:13
作者
Greten, TF
Blum, HE
Manns, MP
Geissler, M
机构
[1] Hannover Med Sch, Abt Gastroenterol Hepatol & Endoskrinol, D-30625 Hannover, Germany
[2] Univ Freiburg, Med Klin 2, D-7800 Freiburg, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2006年 / 44卷 / 01期
关键词
liver; chemotherapy; cancer;
D O I
10.1055/s-2005-858932
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma is one of the most common cancers worldwide. The incidence of this disease is also increasing in the Western world. Typically, HCC is diagnosed when patients have already reached an advanced stage of the disease and the prognosis is poor. Potentially curative treatment options include surgical resection or liver transplantation and can be offered to patients with adequate liver function and tumour stage. Other non-surgical treatment options such as radiofrequency ablation, cryoablation, ethanol or acetic acid injection, transarteriel chemoembolisation radiation therapy and systemic chemotherapy can be offered either alone or in combination to selected groups of patients. These treatments can improve (tumour-free) survival and in a few cases even cure the patient.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 65 条
[1]  
Allgaier HP, 2003, HEPATOLOGY, V38, p760A
[2]  
Allgaier HP, 1998, INT J CANCER, V79, P601, DOI 10.1002/(SICI)1097-0215(19981218)79:6<601::AID-IJC8>3.0.CO
[3]  
2-F
[4]   Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma [J].
Barbare, JC ;
Bouché, O ;
Bonnetain, F ;
Raoul, JL ;
Rongier, P ;
Abergel, A ;
Boige, V ;
Denis, B ;
Blanchi, A ;
Pariente, A ;
Milan, C ;
Bedenne, L .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) :4338-4346
[5]   Local/regional and systemic treatments of hepatocellular carcinoma [J].
Beaugrand, M ;
N'kontchou, G ;
Seror, O ;
Ganne, N ;
Trinchet, JC .
SEMINARS IN LIVER DISEASE, 2005, 25 (02) :201-211
[6]   Chemoembolization for hepatocellular carcinoma [J].
Bruix, J ;
Sala, M ;
Llovet, JM .
GASTROENTEROLOGY, 2004, 127 (05) :S179-S188
[7]   Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure [J].
Bruix, J ;
Castells, A ;
Bosch, J ;
Feu, F ;
Fuster, J ;
GarciaPagan, JC ;
Visa, J ;
Bru, C ;
Rodes, J .
GASTROENTEROLOGY, 1996, 111 (04) :1018-1022
[8]   Immunotherapeutic strategies for hepatocellular carcinoma [J].
Butterfield, LH .
GASTROENTEROLOGY, 2004, 127 (05) :S232-S241
[9]  
De Ruyck K, 2004, J NUCL MED, V45, P612
[10]  
Deuffic S, 1998, LANCET, V351, P214, DOI 10.1016/S0140-6736(05)78179-4